Thermo Fisher Scientific (Thermo Fisher Scientific) Cash, Cash Equivalents, Marketable Securities

: USD8,077 Mil (As of Dec. 2023)

View and export this data going back to 1980. Start your Free Trial

Thermo Fisher Scientific's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 (USD3,133.00 Mil) to Sep. 2023 (USD6,151.00 Mil) and increased from Sep. 2023 (USD6,151.00 Mil) to Dec. 2023 (USD8,077.00 Mil).

Thermo Fisher Scientific's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (USD4,477.00 Mil) to Dec. 2022 (USD8,524.00 Mil) but then declined from Dec. 2022 (USD8,524.00 Mil) to Dec. 2023 (USD8,077.00 Mil).

Thermo Fisher Scientific Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Thermo Fisher Scientific's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

2,399.00

10,325.00

4,477.00

8,524.00

8,077.00

Thermo Fisher Scientific Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															8,524.00	3,482.00	3,133.00	6,151.00	8,077.00

Thermo Fisher Scientific Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Thermo Fisher Scientific (NYSE:TMO) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Thermo Fisher Scientific Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (Thermo Fisher Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

TMO:Peru TMO:Mexico TN8:Germany TN8:Germany TN8:Germany TMOS34:Brazil TMO:Argentina

Address

168 Third Avenue, Waltham, MA, USA, 02451

Website

https://www.thermofisher.com

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).

Executives

Marc N Casper	officer: Senior Vice President	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti	officer: Executive Vice President	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Stephen Williamson	officer: Sr. VP and CFO	81 WYMAN STREET, WALTHAM MA 02451
Jennifer M Johnson	director	C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Michael A Boxer	officer: Sr. VP and Gen. Counsel	168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt	officer: Sr. VP and Chief HR Officer	168 THIRD AVENUE, WALTHAM MA 02451
Jim P Manzi	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Debora L Spar	director	C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Michel Lagarde	officer: Senior Vice President	450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Ruby R Chandy	director	630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson	officer: Executive Vice President	850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
Joseph R. Holmes	officer: VP & Chief Accounting Officer	168 THIRD AVENUE, WALTHAM MA 02451
R. Alexandra Keith	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra	officer: Chief Accounting Officer	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry	officer: Sr. Vice President	345 E. MAIN STREET, WARSAW IN 46580